Rheumnow Podcast
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Latest Episodes
ACR 2026 Obesity Topic Panel
What stood out about obesity in rheumatology at ACR 2026? Join Drs. Jiha Lee, Akhil Sood, and Michael Putman for RheumNow’s Obesity Topic Panel Recap. The panel discusses research from Orlando and what the findings could mean for the care of patients living with obesity and rheumatic disease.
Best Drug 1st (11.20.2026)
This week Dr Cush makes a case for using your best drug first in rheumatoid arthritis.
ACR2026 SLE Topic Panel
What stood out in systemic lupus erythematosus (SLE) at ACR 2026? Join Drs. Jack Cush, Alfred Kim, Sheila Reyes, and Andrea Fava for RheumNow’s SLE Topic Panel Recap. The panel shares the lupus research that caught their attention in Orlando and discusses what the findings could mean for everyday patient care.
ACR 2026 ILD Topic Panel
What stood out in interstitial lung disease (ILD) at ACR 2026? Join Drs. Jack Cush, Elena Joerns, Janet Pope, and Daric Mueller, PA-C for RheumNow’s ILD Topic Panel Recap. The panel highlights research from Orlando and discusses what the findings could mean for rheumatologists caring for patients with ILD.
ACR 2026 Fibromyalgia Topic Panel
ACR 2026 RheumNow RA Topic Compilation c
Lifestyle Interventions and Biological Effects in RA First theranostic approach to treat difficult-to-treat RA Biologics after Cancer Is it Safe RA-ILD and Lung Cancer Disease Activity in RA-ILD Worse Survival, Unclear Lung Progression Infliximab Biosimilar Switching Anti-CCP Antibody Testing on the Spot
ACR 2026 RheumNow RA Topic Compilation b
JAKi Cardiovascular Safety in Younger Adults Four Joint Fibromyalgia Warning Difficult to Treat RA Use of JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung Disease Good News and Bad News for CCP+ at Risk for RA Combination Therapy in Rheumatoid Arthritis Snippets & SNPs in ILD and Fibrosis CAR-T in Rheumatoid Arthritis will it stay Not Seronegative Rheumatoid Arthritis-Interstitial Lung Disease What Happens to Muscle Mass and Muscle Strength in RA
ACR 2026 RheumNow RA Topic Compilation a
Can a smartphone identify inflammatory arthritis GLP-1 A game changer for lung health Menopause in RA An Under Recognized Burden JAK vs TNFi in RA Can Biomarkers Help us Choose JAK1 TYK2i beats Tofacitinib in Active RA Rosnilimab in RA Why May it be Relatively Safe Can Gut Candida Trigger Rheumatoid Arthritis Maybe Head to Head JAK vs JAK in RA Fibromyalgia and Depression in Rheumatoid Arthritis A New Way to Measure Disease Activity in Rheumatoid Arthritis Study Design and Comparative Effectiven…
ACR 2026: RA Topic Panel
What stood out in rheumatoid arthritis at ACR 2026? Join Drs. Jon Kay, Jack Cush and Artie Kavanaugh for RheumNow’s RA Topic Panel Recap. They discuss the research that caught their attention in Orlando and what the findings could mean for the everyday care of patients with RA.
ACR 2026 RheumNow Lupus Topic Compilation d
The InVivo Wave Hype or Hope 5mg kg HCQ Threshold in SLE Is it Time to Reconsider Lessons learned from ReBioLup data in Lupus Nephritis
ACR 2026 RheumNow Lupus Topic Compilation c
Kidney Transplantation in Lupus Treating joints and weight together TOGETHER PSA Belimumab and Rituximab for SLE A Successful Trial Silent Drifts Non adherence and inflammation in SLE Drugs in Lupus Nephritis Save Kidney Function, Increase Survival Three Factors Shape Vaccine Response in Immune-Mediated Inflammatory Disease
ACR 2026 RheumNow Lupus Topic Compilation b
Lupus Control without Steroid Burden The Lupus Outcomes Gap Block the Antibody Lupus, Myositis, Scleroderma Proteinuria Another one bites the dust in lupus nephritis Tirzepitide Add on or start together in PsA Does the Air we Breathe Shape Lupus
ACR 2026 RheumNow Lupus Topic Compilation a
Statins and eGFR in SLE Long-term Opioid Use in Lupus Does Obesity Play a Role Two targets or one CAR-T in Lupus Nephritis Hydroxychloroquine Blood Levels and Retinopathy Risk When Low Cardiovascular Risk Misses Coronary Plaque Low PREVENT Score, Real Risk Coronary Calcium and Heart Failure in Lupus SGLT2 Inhibitors in Lupus Nephritis Lupus Remission is not one Single Thing
ACR 2026 RheumNow ILD Topic Compilation c
Real World of SARD ILD What are our goals, really, in ILD RA-ILD and Lung Cancer Disease Activity in RA-ILD Worse Survival, Unclear Lung Progression
ACR 2026 RheumNow ILD Topic Compilation b
Does Scl-Ab change predict pulmonary decline in systemic sclerosis Use of JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung Disease Snippets & SNPs in ILD and Fibrosis Interstitial Pneumonia with Autoimmune Features (IPAF)
ACR 2026 RheumNow ILD Topic Compilation a
New Treatments in ILD Mortality and Myositis in ILD Screen-detected ILD in Scleroderma Can we do Pulmonary Testing at Home VALORous Efforts in Dermatomyositis Interstitial Lung Disease
ACR 2026 RheumNow CAR T Topic Compilation
Two targets or one CAR-T in Lupus Nephritis New Rheumatic Disease after CAR-T New Treatments in Scleroderma Early Days CAR T Without Lymphodepletion CAR-T in Rheumatoid Arthritis will it stay Preliminary PK, PD, Clinical and Safety Data of NK019 in Myositis The InVivo Wave Hype or Hope
ACR 2026 RheumNow Fibromyalgia Topic Compilation c
Nociplastic Pain in axSpA Myositis Hurts
ACR 2026 RheumNow Fibromyalgia Topic Compilation b
UPSTAND study widespread pain responding to JAK inhibition Who Manages Fibromyalgia
ACR 2026 RheumNow Fibromyalgia Topic Compilation a
New Therapy for Fibromyalgia Pain in axSpA may Reflect More than Inflammation Fibromyalgia and Depression in Rheumatoid Arthritis Four Joint Fibromyalgia Warning





